Plasma free iron and chemotherapy toxicity (Q70994754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

title

Plasma free iron and chemotherapy toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

S Beare

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

W P Steward

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

volume

347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

issue

8998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

342-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Mechanisms of bleomycin-induced lung damage

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

New concepts of iron and aluminium chelation therapy with oral L1 (deferiprone) and other chelators. A review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(96)90530-9

7 January 2021

10.1016/S0140-6736(96)90530-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598694 AND SRC:MED&resulttype=core&format=json

15 October 2019

1 reference